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Background. The aim of this study was to assess postoperative patient well-being after total
i.v. anaesthesia compared with inhalation anaesthesia by means of validated psychometric tests.
Methods. With ethics committee approval, 305 patients undergoing minor elective
gynaecologic or orthopaedic interventions were assigned randomly to total i.v. anaesthesia
using propofol or inhalation anaesthesia using sevo¯urane. The primary outcome measurement
was the actual mental state 90 min and 24 h after anaesthesia assessed by a blinded observer
using the Adjective Mood Scale (AMS) and the State-Trait-Anxiety Inventory (STAI). Incidence
of postoperative nausea and vomiting (PONV) and postoperative pain level were determined
by Visual Analogue Scale (VAS) 90 min and 24 h after anaesthesia (secondary outcome
measurements). Patient satisfaction was evaluated using a VAS 24 h after anaesthesia.
Results. The AMS and STAI scores were signi®cantly better 90 min after total i.v. anaesthesia
compared with inhalation anaesthesia (P=0.02, P=0.05, respectively), but equal 24 h after both
anaesthetic techniques (P=0.90, P=0.78, respectively); patient satisfaction was comparable
(P=0.26). Postoperative pain was comparable in both groups 90 min and 24 h after anaesthesia
(P=0.11, P=0.12, respectively). The incidence of postoperative nausea was reduced after total
i.v. compared with inhalation anaesthesia at 90 min (7 vs 35%, P<0.001), and 24 h (33 vs 52%,
P=0.001).
Conclusion. Total i.v. anaesthesia improves early postoperative patient well-being and
reduces the incidence of PONV.
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General anaesthesia can be provided by i.v. or inhaled
volatile anaesthetics. In current practice, both propofol for
total i.v. and sevo¯urane for inhalation anaesthesia are
frequently administered because of their pharmacological
properties providing fast recovery after anaesthesia.1±5
Clear indications for the use of one or the other method
with respect to `minor' outcomes such as postoperative
nausea and vomiting (PONV) and quality of anaesthesia are
lacking. Therefore, preference in daily practice continues to
be based on tradition, consideration of costs or clinical
impression of anaesthesiologists and patients rather than on
large trial evidence.
This randomized, double-blind multi-centre study was
designed to assess the effect of total i.v. anaesthesia with
propofol compared with inhalation anaesthesia with sevo-
¯urane on postoperative patient well-being and major
adverse events in the postoperative period. In addition, we
intended to de®ne preoperative risk factors predicting
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reduced postoperative patient well-being and increased
occurrence of PONV. Our hypothesis was that total i.v.
anaesthesia would show improved postoperative patient
well-being and improved patient satisfaction.
Methods
Patients and interventions
With ethics committee approval in-patients presenting for
minor elective gynaecological or orthopaedic interventions
were screened for study eligibility at the Triemli City
Hospital and the University Hospital Zurich, Switzerland.
Patients were admitted to the study according to the
following criteria: (i) ASA classi®cation I or II; (ii) age
between 20 and 80 yr; (iii) German speaking; (iv) absence of
psychiatric diagnosis or psychiatric medication and drug or
alcohol abuse; (v) planned minor gynaecological
intervention (laparoscopic, hysteroscopic, vaginal, or
transabdominal procedures and breast tumour surgery) or
minor orthopaedic surgery on extremities (arthroscopy,
meniscectomy, minor internal ®xation, removal of metal
work, or minor tumour resection); (vi) no speci®c
anaesthetic technique (i.e. regional anaesthesia, total i.v.
or inhalation anaesthesia) requested or preferred.
Primary and secondary outcome measures
The primary outcome measure was patient well-being
assessed by the Adjective Mood Scale (AMS)6 and the
short form of the State-Trait-Anxiety Inventory (STAI).7 8
Additionally, patient satisfaction was assessed to establish a
possible correlation to patient well-being as a quality
indicator of anaesthesia. Additional secondary outcome
measures were the cumulative incidence of PONV and the
level of postoperative pain.
Study sequence
Preoperative period
On the day before surgery, 1 h after the routine preoperative
visit, written informed consent was obtained and the
preoperative interview was performed by an independent
observer (Fig. 1). Patient characteristics (age, gender, social,
and educational status), basic medical history, history of
previous general anaesthesia and previous PONV, and the
relevant ®ndings of a physical examination were recorded.
Subsequently, the patient's preoperative emotional state
(e.g. patient well-being) was evaluated using the psycho-
metric test sequence (AMS and STAI).
Randomization and blinding
After the interview, the patients were assigned randomly to
receive total i.v. anaesthesia with propofol or inhalation
anaesthesia with sevo¯urane: computer-generated randomi-
zation, strati®ed by centre and intervention, was developed
by a statistician (R.K.). Allocation concealment was ensured
by enclosing assignments in sealed, sequentially numbered
envelopes distributed to both centres. For each patient, the
corresponding envelope was attached to the pre-medication
notes and was opened the next day in the operating room
before induction of anaesthesia. Study personnel (inde-
pendent observer) and patients were blinded to group
assignment for the time from allocation until after the
second postoperative interview 24 h after anaesthesia.
Fig 1 Study pro®le. TIVA=total i.v. anaesthesia group;
INHAL=sevo¯urane inhalation anaesthesia group.
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Anaesthesia
The patients received pre-medication with oral midazolam
7.5 mg 1 h before induction of anaesthesia. After application
of routine monitoring, standardized anaesthesia induction
for all patients was performed using sequential boluses of
i.v. fentanyl (3 mg kg±1), lidocaine 1% (10 mg) and propofol
(1.4 mg kg±1). Rocuronium (0.6 mg kg±1) was given for
neuromuscular block after loss of the eyelash re¯ex and the
trachea was intubated. Anaesthesia was maintained with
an i.v. propofol infusion 2±8 mg kg±1 h±1 or inhaled
sevo¯urane titrated to keep haemodynamic variables within
10% of pre-induction levels. Before skin incision, fentanyl
3 mg kg±1 i.v. was given in both groups. In the case of
inadequate depth of anaesthesia indicated by movement,
swallowing, sweating, tachycardia, or increase in arterial
pressure (>10% of pre-induction level), the end-expiratory
concentration of sevo¯urane or the rate of propofol infusion
were increased. If this was not suf®cient, additional fentanyl
(1.5 mg kg±1) i.v. was given. Controlled mechanical
ventilation with oxygen/air (inspired oxygen fraction=0.5)
was applied. Before completion of surgery, all patients
received pro-paracetamol 2 g i.v. No prophylactic anti-
emetics were given. The duration of surgery and anaesthesia
and the dosages of drugs were recorded on a separate
evaluation sheet by the anaesthesiologist in charge of the
patient.
Postoperative period
Ninety minutes after the termination of anaesthesia a second
interview (psychometric test sequence) was carried out by
the same independent observer who performed the pre-
operative tests. The occurrence of both postoperative nausea
or vomiting (yes/no) was recorded. The intensity of pain
was assessed using a Visual Analogue Scale (VAS) based
on a total score between 0 and 10 (0=no pain and 10=worst
pain). On the ®rst postoperative day, 24 h after anaesthesia,
the interview with AMS, STAI, assessment of postoperative
nausea, vomiting and postoperative pain was repeated by
the same observer. Additionally, patient satisfaction was
evaluated using a VAS (0=not satis®ed, 10=completely
satis®ed). After the interview, use of analgesics and anti-
emetics within 24 h after the operation was recorded from
the charts. Subsequently, all data were entered in a
Microsoft Access 2000â database.
Psychometric tests
AMS
The Zerssen AMS6 proved to be a valid instrument in the
assessment of affective state in German9 and French-
speaking patients.10 It has been successfully used in patients
after anaesthesia.11 The questionnaire consists of 28 paired
items representing different dimensions of affects. Each pair
is rated by the patient and the answers are scored (`rather
happy'=0 points, `rather unhappy'=2 points, `neither of
both'=1 point). Therefore, scoring ranges from 0 to 56
points with decreased well-being represented by higher
scores.
STAI
The Spielberger STAI is a reliable and sensitive measure of
anxiety in applied psychology research and in anaesthesia.12
In contrast to the original version with 40 items,8 the
validated short form of the inventory7 to assess state has six
items (`calm', `tense', `feel upset', `relaxed', `feel content',
`worried'). Every item is rated by the patient and answers
are scored (`not at all'=1 point, `somewhat'=2 points,
`moderately'=3 points, `very'=4 points). Scoring ranges
from 6 to 24 points, and higher scores indicate increased
anxiety.
Practicability and reliability of the AMS and STAI 90
min after general anaesthesia was tested in a pilot study
performed in 50 patients at the Triemli City Hospital during
March 2000. All 50 patients were able to answer the test
sequence in an adequate manner. The preoperative mean
(SD) value for AMS in this pilot study was 13.1 (11.5)
(median 11, range 0±46). It increased 90 min after general
anaesthesia to 20.8 (11.4) (21, 0±43) (P<0.01). The
preoperative mean value for STAI was 17.8 (3.8) (16, 6±
24), decreasing to 15.8 (3.3) (15, 6±21) (P<0.001) 90 min
after anaesthesia. The Crohnbach a statistic for AMS was
0.93 and for STAI 0.85, that is the test reliability was high
for this setting.
Statistics
Sample size calculation
All statistical analyses were performed using SPSS for
Windows 9.0. Assuming a difference of 0.5 SD in the
psychometric test sequence (AMS and STAI) with an a-
error level=0.05 (one-sided) a sample size of 75 patients for
each group (total i.v., inhalation anaesthesia and gynaeco-
logic, orthopaedic procedures, respectively) was calculated
to yield a test power of greater than 80%. Therefore, a
minimum of 300 patients had to be included in the study.
Data analysis
Data were analysed (two-sided) according to a pre-estab-
lished plan by a statistician. Differences in the results of
psychometric testing (AMS and STAI) between total i.v.
and inhalation anaesthesia were compared using the Mann±
Whitney U-test for independent samples adjusted for
multiple comparisons (Bonferroni±Dunn correction). The
incidences of postoperative nausea and also vomiting
between groups were compared using the c2-test. A
prede®ned subgroup analysis for primary and secondary
outcome measurements was performed for gynaecological
and orthopaedic procedures. Differences in patient satisfac-
tion and in postoperative pain were tested using the t-test for
independent samples. Risk factor analysis predicting
reduced postoperative patient well-being (postoperative
increased AMS and STAI as continuous variables) was
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performed on the basis of pre- and intraoperative variables
by multiple regression analysis. A risk factor analysis to
predict PONV (nominal variables yes/no) was done using
logistic regression. Data are presented as mean (SD). In
addition median and range are indicated for psychometric
test results.
Results
A total of 305 patients were included in the study between
July 4, 2000 and July 10, 2001, 145 at the Triemli City
Hospital Zurich and 160 at the University Hospital Zurich.
Four patients were excluded from the study protocol after
randomization as a result of cancelled surgery. 155 patients
had general anaesthesia with propofol and 146 patients
inhalation anaesthesia using sevo¯urane. Five patients were
not willing to complete the psychometric testing in the
postoperative period; these patients were included in the
statistical analysis (Fig. 1). The two study groups were
comparable with respect to baseline patient, clinical and
psychological characteristics, and the distribution of
planned interventions. In both groups the duration of
surgery and anaesthesia were comparable. Similar dosages
of propofol for induction and of fentanyl during anaesthesia
were given. The dosage of propofol for maintenance in the
TIVA group was 1446 (896) mg, and the mean end-
expiratory concentration of sevo¯urane was 1.3 (0.5) MAC
(MAC=minimal alveolar concentration) (Table 1).
Primary outcome measurements
The AMS levels were comparable for both groups at
baseline (P=0.83). They increased in both groups 90 min
after anaesthesia and decreased again after 24 h to
approximately the baseline values. A signi®cantly lower
AMS 90 min after total i.v. anaesthesia indicated improved
well-being as compared with inhalation anaesthesia
(P=0.02). This difference between groups disappeared
after 24 h (Table 2). The test reliability during the study
period was high (Crohnbach a=0.89±0.92). The baseline
STAI was also similar for both anaesthetic groups (P=0.37).
Ninety minutes after total i.v. anaesthesia STAI decreased,
whereas STAI decreased only 24 h after inhalation anaes-
thesia. There was a signi®cant difference between the two
anaesthetic techniques 90 min after anaesthesia (P=0.05)
indicating lower anxiety after total i.v. anaesthesia. The test
reliability for both psychometric tests was high (Crohnbach
a=0.79±0.82). The changes in both psychometric tests
during the test period (baseline, 90 min and 24 h after
anaesthesia) were comparable for gynaecological and
orthopaedic procedures. There was a signi®cantly lower
AMS for the gynaecology patients 90 min after anaesthesia
(P=0.03).
Secondary outcome measurements
Patient satisfaction assessed by a VAS 24 h after anaesthesia
was similar in both groups (9.6 (1.0) for the TIVA group vs
9.4 (1.5) for the inhalation anaesthesia, P=0.26). Occurrence
of both nausea and vomiting was signi®cantly higher 90 min
and 24 h after anaesthesia in the inhalation compared with
the total i.v. anaesthesia group (Table 3). Also, anti-emetic
drugs were more frequently given after inhalation anaes-
thesia (Table 4). The cumulative incidence of PONV
increased for both techniques in the ®rst 24 h after
anaesthesia. For gynaecological procedures, the incidence
of PONV was signi®cantly reduced 90 min and 24 h after
total i.v. anaesthesia compared with inhalation anaesthesia
(P<0.001 and P=0.006, respectively). For orthopaedic
procedures, this effect was only signi®cant for postoperative
nausea 90 min after total i.v. anaesthesia (P=0.002): at 24 h,
no difference between the two anaesthetic regimens could
be shown (P=0.38). Postoperative pain levels were similar
for both anaesthetic techniques. However, the use of opioids
Table 2 Primary outcome measurement: patient well-being. TIVA=total i.v.
anaesthesia group; INHAL=sevo¯urane inhalation anaesthesia group. Data
are presented as mean (SD) (median/minimum/maximum)
TIVA INHAL P
(n=155) (n=146)
AMS
Baseline 12.0 (10.0) (10/0/46) 11.5 (9.2) (9/0/40) 0.83
90 min after anaesthesia 20.9 (10.8) (21/0/45) 23.6 (11.1) (23/0/48) 0.02
24 h after anaesthesia 13.3 (9.6) (12/0/44) 13.7 (10.4) (11/0/42) 0.90
STAI
Base line 11.3 (3.7) (10/6/24) 11.4 (3.2) (11/5/19) 0.37
90 min after anaesthesia 10.6 (3.5) (10/6/21) 11.5 (4.0) (11/6/24) 0.05
24 h after anaesthesia 9.7 (2.8) (9/6/18) 9.8 (2.4) (9/6/18) 0.78
Table 1 Patient characteristics; surgery and anaesthesia data. TIVA=total i.v.
anaesthesia group; INHAL=sevo¯urane inhalation anaesthesia group;
MAC=minimal alveolar concentration. Data are presented as mean (SD or
range) or n (%), respectively
TIVA INHAL
(n=155) (n=146)
Age, yr 46 (20±77) 48 (20±79)
Male/female ratio, n (%) 43/112 (28/72) 42/104 (29/71)
ASA I/II, n (%) 86/69 (56/44) 78 (53/47)
Previous general anaesthesia, n (%) 121 (78) 112 (77)
Previous PONV, n (%) 35 (23) 33 (23)
Fear of anaesthesia, n (%) 82 (53) 81 (56)
Gynaecological procedures, n (%) 73 (47) 69 (47)
Orthopaedic procedures, n (%) 82 (53) 77 (53)
Duration of surgery, min 88 (47) 93 (49)
Duration of anaesthesia, min 155 (54) 157 (54)
Dosage of propofol (induction), mg 122 (41) 120 (41)
Dosage of propofol (maintenance), mg 1446 (896) ±
Mean sevo¯urane concentration, MAC ± 1.3 (0.5)
Dosage of fentanyl (induction), mg 0.2 (0.1) 0.2 (0.1)
Dosage of fentanyl (maintenance), mg 0.5 (0.3) 0.5 (0.1)
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was signi®cantly more frequent after inhalation anaesthesia
(Tables 3 and 4). There were no differences between the
gynaecological and the orthopaedic groups regarding post-
operative pain.
Risk factor analysis
In terms of increased postoperative AMS the following
independent pre- and intraoperative determinants of
impaired postoperative patient well-being were identi®ed:
preoperatively increased STAI, gynaecological procedures,
inhalation anaesthesia with sevo¯urane, duration of anaes-
thesia and female gender (Table 5).
The predictability of multiple regression analysis
(adjusted r2) using the AMS was 31%, whereas the
predictability using the STAI was only 14%. Independent
risk factors for PONV for the entire study population were
inhalation anaesthesia with sevo¯urane, gynaecological
interventions, and a preoperatively increased AMS
(Table 6). In patients with a history of general anaesthesia,
previous PONV was an additional risk factor (OR=3.12,
95% CI=1.32±7.40). The inclusion of postoperative factors
in the risk analysis revealed use of postoperative opioids not
to be signi®cantly associated with PONV (OR=1.59, 95%
CI=0.70±3.61).
Discussion
This trial demonstrates that total i.v. anaesthesia with
propofol was associated with improved early postoperative
well-being as compared with inhalation anaesthesia using
sevo¯urane. The occurrence of PONV was signi®cantly
lower after total i.v. anaesthesia. Improved well-being and
reduced incidence of PONV after total i.v. anaesthesia was
particularly pronounced in the group of patients undergoing
gynaecological procedures. The intensity of postoperative
pain was comparable using both techniques and patient
satisfaction was similarly high after inhalation and total i.v.
anaesthesia.
Well-being represents the subjective patient condi-
tion6 9 10 and has been proposed as a useful surrogate end-
point in anaesthetic quality assessment.11 However, in the
context of general anaesthesia, an attempt to evaluate
possible differences of quality only between different
anaesthetic techniques has never been made. In the present
study, an established psychometric test, Zerssen's AMS6
was used to assess subjective patient state before and after
anaesthesia. Being a central issue in the perioperative
subjective experience, anxiety was speci®cally determined
by Spielberger's STAI.7 The combination of both tests
allowed the assessment of different qualities of the patient's
affective state perioperatively, whereas most studies on
Table 3 Secondary outcome measurements: incidence of postoperative
nausea and vomiting; postoperative pain. TIVA=total i.v. anaesthesia group;
INHAL=sevo¯urane inhalation anaesthesia group; VAS=visual analogue
scale (0=no pain, 10=strong pain). Data are presented as mean (SD) or n (%),
respectively
TIVA INHAL P
(n=155) (n=146)
Cumulative incidence of postoperative
nausea
90 min after anaesthesia, n (%) 10 (7) 43 (31) < 0.001
24 h after anaesthesia, n (%) 50 (33) 75 (52) 0.001
Cumulative incidence of postoperative
vomiting
90 min after anaesthesia, n (%) 4 (3) 13 (9) 0.01
24 h after anaesthesia, n (%) 34 (23) 50 (35) 0.01
Postoperative pain (VAS)
90 min after anaesthesia 3.8 (2.5) 4.3 (2.4) 0.11
24 h after anaesthesia 3.8 (2.4) 4.2 (2.6) 0.12
Table 4 Postoperative medication. TIVA=total i.v. anaesthesia group;
INHAL=sevo¯urane inhalation anaesthesia group; NSAIDs=non-steroidal
anti-in¯ammatory drugs
TIVA INHAL P
(n=155) (n=146)
Acetominophen, n (%) 122 (79) 118 (81) 0.42
NSAIDs, n (%) 28 (18) 23 (16) 0.23
Opioids, n (%) 105 (68) 113 (77) 0.04
Anti-emetics, n (%) 33 (21) 55 (37) 0.001
Table 5 Risk factors for decreased postoperative patient well-being.
Adjusted r2=0.31, P=0.01, b=standardised regression coef®cient
b P
Decreased preoperative well-being 0.44 <0.001
Gynaecological procedures 0.28 <0.001
Use of sevo¯urane 0.15 0.003
Duration of anaesthesia 0.13 0.01
Gender (male vs female) ±0.16 0.01
Increased preoperative anxiety 0.10 0.10
Fear of anaesthesia 0.08 0.17
Smoking ±0.04 0.43
Age (<50 vs >50 yr) 0.4 0.48
Obesity (BMI >35 vs <35) 0.03 0.51
Table 6 Risk factors for postoperative nausea and vomiting. OR=odds ratio;
CI=con®dence interval
OR 95% CI
Use of sevo¯urane 7.80 3.48±13.51
Gynaecological procedures 3.0 1.23±7.26
Decreased preoperative well-being 1.06 1.02±1.11
Age (<50 vs >50 yr) 1.01 0.99±1.04
Duration of anaesthesia 1.00 0.99±1.01
Fear of anaesthesia 2.1 0.92±4.82
Increased preoperative anxiety 0.90 0.79±1.02
Gender (female vs male) 2.1 0.65±6.78
Obesity (BMI >35 vs <35) 0.47 0.16±1.41
Smoking 0.43 0.19±0.96
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quality of anaesthesia did not discriminate between
affective and cognitive patient perception.13 14 Both tests
revealed a signi®cantly better affective state in the early
postoperative period after total i.v. anaesthesia compared
with inhalation anaesthesia.
The reduction of PONV may be the main determinant of
this improved affective state. PONV remains a major patient
complaint related to anaesthesia15 and a frequent endpoint
in studies comparing total i.v. with inhalation
anaesthesia.16±18 A signi®cantly reduced incidence of
PONV after i.v. anaesthesia was suggested in a number
of studies.19 20 However, most studies revealed a variety of
methodological and statistical problems (small study popu-
lations, case mix, use of different anaesthetics, non-
standardized use of opioids, heterogeneous de®nition of
PONV). Two large meta-analyses showed evidence of a
signi®cantly reduced incidence of PONV up to 6 h after total
i.v. anaesthesia.19 20 This effect was also observed recently
in a large controlled trial for up to 24 h postoperatively by
Visser and co-workers.17 However, some confounding
factors in this study have to be considered when interpreting
the results, these are the use of nitrous oxide as a potential
risk factor for PONV in the inhalation group only, inclusion
of both inpatients and outpatients, and use of different
anaesthetic induction regimens and techniques. In the
present study, the effect on PONV of total i.v. and inhalation
anaesthesia was evaluated without the use of nitrous oxide
in inpatients only with one standardized induction regimen.
Still, a high overall incidence of PONV was observed. The
occurrence of PONV in the total i.v. anaesthesia group was
signi®cantly reduced in the early postoperative period, then
increased in the ®rst 24 h postoperatively, but remained
signi®cantly lower compared with the inhalation anaesthe-
sia group. The anti-emetic effect of propofol in subanaes-
thetic concentrations may be responsible for this ®nding.21
Pain, another important patient complaint in the post-
operative period, may affect well-being. Opioid use was
signi®cantly higher in the sevo¯urane anaesthesia group to
achieve a comparable intensity of postoperative pain. This
®nding may indicate that patients had more pain after
inhalation anaesthesia and this may have in¯uenced well-
being in the early postoperative period. Furthermore,
increased opioid analgesic usage is known to promote
PONV.22 However, this postoperative use of opioid anal-
gesics was not an independent determinant of PONV in the
risk factor analysis.
This study did not address any aspects of costs and
economy. However, today clinicians are faced with the need
to improve patient outcome at minimal costs. Total i.v.
anaesthesia is supposed to be more expensive than inhal-
ation anaesthesia.17 23 24 Cost assessment and cost-bene®t
analysis in anaesthesia have proved to be complex.
Comparing costs of anaesthetic drugs alone (direct costs)
is inappropriate, as postoperative adverse eventsÐsuch
as PONVÐmay be associated with secondary expenses
(indirect costs). Thus, identi®cation of risk groups for
adverse outcome appears to be desirable. The preoperative
risk factor analysis of the present study revealed that
patients undergoing gynaecological procedures are at high-
est risk for impaired postoperative well-being. They also
suffer from PONV in more than 60% of cases after
inhalation anaesthesia. In contrast, signi®cantly improved
well-being and a signi®cantly reduced incidence of PONV
in this group was demonstrated after total i.v. anaesthesia.
We believe the use of this more expensive anaesthetic drug
in this speci®c risk group to be justi®ed not only from the
medical but also from the economical point of view.
In contrast to the present results, many studies comparing
propofol with sevo¯urane anaesthesia failed to show any
difference between the two anaesthetic techniques in terms
of improved patient outcome (e.g. recovery, patient satis-
faction, PONV).1 3 5 25 Study designs with a pragmatic
approach of daily clinical practice,25 but also shortcomings
of surrogate endpoints1 3 may be responsible for these
®ndings. However, applying a strict anaesthetic regimen
with minimal variations, which may in part not re¯ect
common practice, revealed a signi®cant difference in
psychometric testing.
In conclusion, when compared with sevo¯urane we have
shown that propofol for maintenance of general anaesthesia
improves early postoperative patient well-being and re-
duces, but does not eliminate the risk of PONV, especially
in the subgroup of patients undergoing gynaecological
procedures.
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